Educational information, not medical advice — ask your doctor or midwife.
Mai Dong is the dried tuber of Ophiopogon japonicus, a low-growing plant in the lily family native to China, Japan, and Korea. It is one of the most widely used herbs in Chinese and Japanese (Kampo) medicine, appearing in dozens of classical formulas and modern preparations. In TCM it falls into the category of Yin-nourishing herbs — meaning it is thought to restore moisture and coolness to organs that have become dry or overheated.
Its active steroidal saponins (especially ophiopogonins) appear to calm inflammation in the airways, support the heart's electrical rhythm, and help cells handle blood sugar more efficiently. The polysaccharides it contains act a bit like soluble fiber — they support gut health and appear to gently regulate immune responses. Modern research has focused especially on heart protection and blood sugar balance, with several Chinese clinical trials testing it in these areas.
In traditional practice, the dried root is simmered into a tea or decoction — often with other herbs in formulas like Mai Men Dong Tang (for dry cough) or Sheng Mai San (for heart support). Modern products offer standardized extracts as capsules, tablets, or granules that dissolve in water. For dry mouth or throat issues, a slow-simmered tea or syrup is particularly practical. For metabolic or cardiac support, standardized extracts or formula tablets are more consistent.
Mai Dong appears in the Shennong Bencao Jing — China's foundational herbal classic compiled around the first century CE — where it was classified as a top-grade herb safe for long-term use. It has remained in continuous clinical use in China, Japan (as Bakumondo), and Korea for over 2,000 years, making it one of the longest-running herbal medicines in human history. It remains an official medicine in the Chinese Pharmacopoeia today.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Mai Dong (Ophiopogon) is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.